Common Single-Nucleotide Polymorphisms in DNA Double-Strand Break Repair Genes and Breast Cancer Risk
暂无分享,去创建一个
B. Ponder | D. Easton | P. Pharoah | K. Pooley | A. Dunning | J. Tyrer | C. Baynes | K. Driver | E. Azzato
[1] D. Easton,et al. Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort , 2008, Breast Cancer Research.
[2] J. Hoeijmakers. Genome maintenance mechanisms are critical for preventing cancer as well as other aging-associated diseases , 2007, Mechanisms of Ageing and Development.
[3] L. Skoog,et al. Intact Mre11/Rad50/Nbs1 complex predicts good response to radiotherapy in early breast cancer. , 2007, International journal of radiation oncology, biology, physics.
[4] F. Bunz,et al. Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation , 2007, Oncogene.
[5] Alison M Dunning,et al. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk , 2007, Breast Cancer Research.
[6] Douglas F. Easton,et al. Tagging Single Nucleotide Polymorphisms in the BRIP1 Gene and Susceptibility to Breast and Ovarian Cancer , 2007, PloS one.
[7] R. Scott,et al. The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation Carriers , 2007, Cancer Epidemiology Biomarkers & Prevention.
[8] S. West,et al. Role of RAD51C and XRCC3 in Genetic Recombination and DNA Repair* , 2007, Journal of Biological Chemistry.
[9] M. Lathrop,et al. A naturally occurring genetic variant of human XRCC2 (R188H) confers increased resistance to cisplatin-induced DNA damage. , 2007, Biochemical and biophysical research communications.
[10] T. Helleday,et al. RAD51C (RAD51L2) is involved in maintaining centrosome number in mitosis , 2007, Cytogenetic and Genome Research.
[11] Paul D.P. Pharoah,et al. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. , 2007, Journal of the National Cancer Institute.
[12] A. Spurdle,et al. Mutation analysis of five candidate genes in familial breast cancer , 2006, Breast Cancer Research and Treatment.
[13] Nazneen Rahman,et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles , 2006, Nature Genetics.
[14] D. Easton,et al. Models of genetic susceptibility to breast cancer , 2006, Oncogene.
[15] S. Seal,et al. A genome wide linkage search for breast cancer susceptibility genes , 2006, Genes, chromosomes & cancer.
[16] M. Daly,et al. Evaluating and improving power in whole-genome association studies using fixed marker sets , 2006, Nature Genetics.
[17] J. Cerhan,et al. Role of the Nijmegen Breakage Syndrome 1 Gene in Familial and Sporadic Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.
[18] J. Chang-Claude,et al. Genetic Polymorphisms in the DNA Double-Strand Break Repair Genes XRCC3, XRCC2, and NBS1 Are Not Associated with Acute Side Effects of Radiotherapy in Breast Cancer Patients , 2006, Cancer Epidemiology Biomarkers & Prevention.
[19] S. Cantor,et al. BACH1 is a DNA repair protein supporting BRCA1 damage response , 2006, Oncogene.
[20] S. Chanock,et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses , 2006, Human Genetics.
[21] A. Whittemore,et al. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk , 2005, International journal of cancer.
[22] Qing Chen,et al. The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population. , 2005, Cancer genetics and cytogenetics.
[23] S. Gabriel,et al. Efficiency and power in genetic association studies , 2005, Nature Genetics.
[24] J. Ott,et al. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia , 2005, Nature Genetics.
[25] D. Noh,et al. Genetic Polymorphisms of Selected DNA Repair Genes, Estrogen and Progesterone Receptor Status, and Breast Cancer Risk , 2005, Clinical Cancer Research.
[26] T. Ørntoft,et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.
[27] D. Gertig,et al. RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women. , 2005, Cancer letters.
[28] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[29] R. Bristow,et al. Defective DNA Strand Break Repair after DNA Damage in Prostate Cancer Cells , 2004, Cancer Research.
[30] P. Sung,et al. Effects of Tumor-associated Mutations on Rad54 Functions* , 2004, Journal of Biological Chemistry.
[31] Nazneen Rahman,et al. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. , 2004, American journal of human genetics.
[32] R. Elston,et al. Optimal two‐stage genotyping in population‐based association studies , 2003, Genetic epidemiology.
[33] Christopher A. Haiman,et al. Choosing Haplotype-Tagging SNPS Based on Unphased Genotype Data Using a Preliminary Sample of Unrelated Subjects with an Example from the Multiethnic Cohort Study , 2003, Human Heredity.
[34] Nicklas Raun Jacobsen,et al. No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[35] C. Ulrich,et al. Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[36] G. Colditz,et al. No association between a stop codon polymorphism in RAD52 and breast cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[37] Paul D P Pharoah,et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. , 2002, Human molecular genetics.
[38] B. Ponder,et al. Effect of germ-line genetic variation on breast cancer survival in a population-based study. , 2002, Cancer research.
[39] S. Jackson,et al. Sensing and repairing DNA double-strand breaks. , 2002, Carcinogenesis.
[40] J. Sambrook,et al. Dominant negative ATM mutations in breast cancer families. , 2002, Journal of the National Cancer Institute.
[41] N E Day,et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes , 2002, British Journal of Cancer.
[42] S. West,et al. Complex formation by the human RAD51C and XRCC3 recombination repair proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[43] N E Day,et al. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study , 2001, Genetic epidemiology.
[44] J. Hoeijmakers,et al. Chromosomal stability and the DNA double-stranded break connection , 2001, Nature Reviews Genetics.
[45] K. Khanna,et al. DNA double-strand breaks: signaling, repair and the cancer connection , 2001, Nature Genetics.
[46] Richard D. Wood,et al. Human DNA Repair Genes , 2001, Science.
[47] A. Harris,et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. , 2000, Cancer research.
[48] Y. Shiloh,et al. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products , 2000, Nature.
[49] D. Easton. How many more breast cancer predisposition genes are there? , 1999, Breast Cancer Research.
[50] N. Day,et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.
[51] M. Oshimura,et al. The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells. , 1999, Mutation research.
[52] C K Osborne,et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[54] J L Kelsey,et al. Radiation and other environmental exposures and breast cancer. , 1993, Epidemiologic reviews.